The global chemical maker Bayer is backing an expanded effort to shield itself from lawsuits alleging its popular weedkiller ...

Bayer seeks European approval of extended 6-month treatment interval for Eylea 8 mg to treat nAMD & diabetic macular edema: Berlin Tuesday, February 11, 2025, 10:00 Hrs [IST] Baye ...

FILE PHOTO: Stefan Oelrich, member of the Board of Management and head of Pharmaceuticals Division of Bayer AG, speaks during an interview on the sidelines of the 38th Annual JP Morgan Healthcare ...

In the latest iteration of See Your Risks, Bayer takes aim at denial among millennials and Gen Xers when it comes to heart ...

Republicans in the Iowa Senate advanced a bill Wednesday that would limit lawsuits by Iowans seeking compensation for ...

On January 21, a Northern District of California Court denied Plaintiff Tevra Brands LLC’s (“Tevra’s”) Motion for a New Trial, after a Jury found ...

The fight for dominance between Regeneron and Bayer’s big blockbuster eye drug Eylea and Roche’s rival Vabysmo is playing out ...

Berlin: Bayer has announced the submission of a marketing authorization application to the European Medicines Agency (EMA), ...

This collaboration supports the "Protect Your Heart" national awareness campaign, sponsored by Bayer and Al-Dawaa Medical ...

Oelrich said there was also no reason to split Bayer, whose businesses span agrochemicals, pharmaceuticals and non-prescription drugs. "We function with three very independent businesses," he said.